Deep Dive: Deckers Outdoor Corp ($DECK)
Deckers trades at about 11x earnings as investors question whether UGG and HOKA can sustain growth after generating 97% of FY26 revenue.
Deckers trades at about 11x earnings as investors question whether UGG and HOKA can sustain growth after generating 97% of FY26 revenue.
@thecontracap @jclarkson203 Just a reminder that those $PSA yield 240 bps wide of the 10 yr. During GFC, EBITDA of PSA dropped less than 10%. They need to drop more than 80% for distribution to be in trouble. I’ll just deal with the vol. if no taxes in IRA etc. Then it’s a no brainer by my reasoning.
@jclarkson203 Again, it’s about knowing what I own. IDGAF if $PSA pref goes down. I’ll buy more.
I’ll take the other side of that During the GFC, EBITDA declined less than 10% for $PSA JPM was fine, but other big bank almost went under This is a “negative art” where you want to eliminate that tail risk Dimon there, fine. Dimon not there. Not sure. Lehman and Wachovia wasn’t so lucky.
Because when shit hits the fan, I know that $PSA interest/pref is covered 6.1 times I don’t know how to read a bank balance sheet I know that you probably can’t make a $78 bn of self storage EBITDA go down more than 80% I know what I know. JPM is probably fine as long as Dimon is there.
@MBrooks87621 $tenb
@BryanFaulkCPA The current policy limiting new purchases is by default forcing Invitation to become a buyback machine IMO, it’s a gift from the politicians the same way that $NVR’s debt holders force them to use options on land after the bankruptcy
Steve Eisman argues Jensen Huang’s resignation unwinds Nvidia’s circular-financing AI stack, ending the one-trade AI market; he also…
Grand Theft Auto VI launched to a 99 Metacritic score after estimated $1.5 billion to $2 billion development and marketing spending,…
AppLovin’s e-commerce advertiser base doubled to 22,061 stores since August, lifting CPMs roughly 46% as more products monetize previously…
Natera grew Q3 revenue 34% to $794 million, raised 2026 guidance to $3.005 billion to $3.035 billion, and named oncology head Solomon…
Intuit’s $3.68 billion Mailchimp sale removes a noncore unit as TurboTax shifts to assisted filing and Credit Karma faces volume pressure.
Manchester United, MANU, trades at 15.17x forward EV/EBITDA despite flat fiscal 2027 EBITDA guidance, £729 million of net debt and rising…
Netflix’s WWE deal pairs 52 weeks of programming with its ad-supported tier, while Peter Rice takes over content amid layoffs and Bela…
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual…
Qualcomm’s Q4 FY2026 review assesses its semiconductor business, moat, financials and valuation amid a chip-sector rebound.
Marvell's Lumentum deal secures laser supply for AI networking and supports its $20 billion fiscal 2028 revenue target.
POST · long Post Holdings remains a large position after the stock's recent decline.
Evolus posted 21% quarterly revenue growth as U.S. facial-injectable spending bottoms, while making progress toward GAAP profitability.
Special-situations survey flags Cooper’s $3 billion buyback, Grab’s $900 million repurchase, and Beretta’s $44.80 partial tender for Sturm…
Weichai Power built a global engine group through Baudouin and a 46% stake in PSIX, positioning both for large-bore generator demand from…
Pioneer Bancorp’s acquisitions lifted loans 13.6% and Q2 net interest margin to 4.30%, but expenses, weaker profitability ratios and a…
STMicroelectronics, Navitas and Wolfspeed offer contrasting power-semiconductor cases tied to NVIDIA’s 800V AI data-center architecture,…
Offshore drillers have secured 105 rig-years by September, 42% above all of 2025, as national oil companies lock up long-term capacity.
Jackson Financial administers $287 billion in retirement accounts while a report says its captive, hedge-loss installment plan and…
Copart's U.S. insurance volumes fell 7.5% in 4Q26, largely from one customer loss, while international insurance units rose 11.2% and…
Viridian Therapeutics is building a shared commercial platform for Lumvoa and investigational elegrobart in thyroid eye disease, with…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.